These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31702530)

  • 1. Activity of (-)-Camphene Derivatives Against Mycobacterium tuberculosis in Acidic pH.
    de Carvalho HC; Ieque AL; Valverde TL; Baldin VP; Meneguello JE; Campanerut-Sá PAZ; Vandresen F; Ghiraldi Lopes LD; Passos Souza MR; Santos NCS; Dias Siqueira VL; Caleffi-Ferracioli KR; Lima Scodro RB; Cardoso RF
    Med Chem; 2021; 17(5):485-492. PubMed ID: 31702530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel (-)-Camphene-based thiosemicarbazones and evaluation of anti-
    Souza MRP; Coelho NP; Baldin VP; Scodro RBL; Cardoso RF; da Silva CC; Vandresen F
    Nat Prod Res; 2019 Dec; 33(23):3372-3377. PubMed ID: 29792346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.
    Lopes-Ortiz MA; Panice MR; Borges de Melo E; Ataide Martins JP; Baldin VP; Agostinho Pires CT; Caleffi-Ferracioli KR; Dias Siqueira VL; Bertin de Lima Scodro R; Sarragiotto MH; Cardoso RF
    Eur J Med Chem; 2020 Feb; 187():111935. PubMed ID: 31816556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
    Pina RZ; Caleffi-Ferracioli KR; Campanerut-Sá PA; Ghiraldi-Lopez LD; Pavan FR; Siqueira VL; Scodro RB; Cardoso RF
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1535-1538. PubMed ID: 27776597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 12 novel (-)-camphene-based 1,3,4-thiadiazoles against
    F Costacurta G; Souza MR; Sampiron EG; Almeida AL; Baldin VP; Ieque AL; Santos NC; Amaral PH; Silva CC; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF; Vandresen F; Scodro RB
    Future Microbiol; 2020 Jun; 15():723-738. PubMed ID: 32686961
    [No Abstract]   [Full Text] [Related]  

  • 6. Carvacrol activity & morphological changes in Mycobacterium tuberculosis.
    Nakamura de Vasconcelos SS; Caleffi-Ferracioli KR; Hegeto LA; Baldin VP; Nakamura CV; Stefanello TF; Freitas Gauze G; Yamazaki DA; Scodro RB; Siqueira VL; Cardoso RF
    Future Microbiol; 2018 Jun; 13():877-888. PubMed ID: 29877104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of natural and synthetic coumarin derivatives against
    Pires CT; Scodro RB; Cortez DA; Brenzan MA; Siqueira VL; Caleffi-Ferracioli KR; Vieira LC; Monteiro JL; Corrêa AG; Cardoso RF
    Future Med Chem; 2020 Sep; 12(17):1533-1546. PubMed ID: 32820960
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis.
    Hegeto LA; Caleffi-Ferracioli KR; Nakamura-Vasconcelos SS; Almeida AL; Baldin VP; Nakamura CV; Siqueira VLD; Scodro RBL; Cardoso RF
    Tuberculosis (Edinb); 2018 Jul; 111():35-40. PubMed ID: 30029912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazinamide resistance determined by liquid culture at low pH better correlates with genetic mutations in MDR tuberculosis isolates.
    Pang Y; Wang Z; Zheng H; Song Y; Wang Y; Zhao Y
    J Microbiol Methods; 2015 Dec; 119():142-4. PubMed ID: 26506283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eugenol and derivatives activity against Mycobacterium tuberculosis, nontuberculous mycobacteria and other bacteria.
    de Almeida AL; Caleffi-Ferracioli KR; de L Scodro RB; Baldin VP; Montaholi DC; Spricigo LF; Nakamura-Vasconcelos SS; Hegeto LA; Sampiron EG; Costacurta GF; Dos S Yamazaki DA; F Gauze G; Siqueira VL; Cardoso RF
    Future Microbiol; 2019 Mar; 14():331-344. PubMed ID: 30757916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimycobacterial activity of acetone extract and isolated metabolites from folklore medicinal lichen Usnea laevis Nyl. against drug-sensitive and multidrug-resistant tuberculosis strains.
    Tatipamula VB; Annam SSP
    J Ethnopharmacol; 2022 Jan; 282():114641. PubMed ID: 34536516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Microtiter Plate Assay at Acidic pH to Identify Potentiators that Enhance Pyrazinamide Activity Against Mycobacterium tuberculosis.
    Moon CW; Porges E; Taylor SC; Bacon J
    Methods Mol Biol; 2024; 2833():65-77. PubMed ID: 38949702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Mycobacterium tuberculosis activity of essential oil and 6,7-dehydroroyleanone isolated from leaves of Tetradenia riparia (Hochst.) Codd (Lamiaceae).
    Baldin VP; Scodro RBL; Lopes-Ortiz MA; de Almeida AL; Gazim ZC; Ferarrese L; Faiões VDS; Torres-Santos EC; Pires CTA; Caleffi-Ferracioli KR; Siqueira VLD; Cortez DAG; Cardoso RF
    Phytomedicine; 2018 Aug; 47():34-39. PubMed ID: 30166106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
    Che Y; Bo D; Lin X; Chen T; He T; Lin Y
    BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
    Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
    J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
    Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
    Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    Zhang Y; Scorpio A; Nikaido H; Sun Z
    J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazinamide Susceptibility and
    Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.
    Patel H; Jadhav H; Ansari I; Pawara R; Surana S
    Eur J Med Chem; 2019 Apr; 167():1-9. PubMed ID: 30743094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.